This topic contains a solution. Click here to go to the answer

Author Question: When a licensee cannot guarantee the product's quality it is preferable for the licensor to a. ... (Read 68 times)

xclash

  • Hero Member
  • *****
  • Posts: 681
When a licensee cannot guarantee the product's quality it is preferable for the licensor to
 a. export to the market. c. license without the brand name.
  b. license with the brand name. d. create a joint venture.

Question 2

Disposition is the process by which a consumer uses an offering.
 
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ApricotDream

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

C
Licensing without the brand name is the recommended strategy when a licensee is unable to guarantee quality standards. In this way, the licensor receives the benefits of licensing without the risk of damaging its brand image. This may be found in the Licensing section (8-3c).

Answer to Question 2

False




xclash

  • Member
  • Posts: 681
Reply 2 on: Jun 29, 2018
Wow, this really help


ricroger

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Excellent

 

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library